Virgin Galactic Holdings Inc - Class A

NYSE: SPCE
$1.03
+$0.08 (+8.6%)
Closing price May 6, 2024

SPCE Articles

Virgin Galactic stock was up by double-digits after it announced it will open its reservation list for space flights. Other, earth-bound news was driving premarket trading Tuesday morning.
In an overall poor market for growth stocks Thursday, meme stocks mostly traded lower. As always, however, there are exceptions.
A cryptocurrency asset firm is paying the first-ever bitcoin dividend and the stock soared, while a space technology company was sinking on news of a new convertible debt offering.
Thursday’s top analyst upgrades and downgrades included Amazon.com, APA, Coupang, FuelCell Energy, GlobalFoundries, Lucid, Meta Platforms (Facebook) and Virgin Galactic.
Stocks were mostly trading lower Wednesday and many were putting up (down?) new 52-week lows.
Tuesday was not shaping up to be a winner on Tuesday. The same was true for meme stocks. As a group, losers outnumbered winners by about three to one.
Here are previews of four company earnings reports due out after markets close Monday.
Here's a look at how several meme stocks were performing as of the early afternoon Wednesday.
The rising price of Bitcoin gave a solid boost to a cryptocurrency exchange on Friday, but Monday morning brought second thoughts.
Monday's top analyst upgrades and downgrades included Disney, Domino's Pizza, Equifax, Micron Technology, NetApp, Occidental Petroleum, U.S. Steel, Virgin Galactic and Western Digital.
Space tourism company Virgin Galactic is having a tough day Friday while DNA testing firm 23andMe is having a good one.
Meme stocks, as a group, posted share price gains on Thursday, but there was one big loser. Another double-digit loss in Friday's premarket trading was hammering a much-discussed space tourism stock.
The last day of the September quarter has been marked mostly by unconvinced traders looking for some last-minute winners.
Meme stocks had another tough day Wednesday, with fewer than 10 posting a gain for the day. Thursday was off to a good start, but then, so did Wednesday.
An Israel-based biotech is soaring in Friday's premarket after its first bone-marrow transplant and Virgin Galactic has run into some trouble with the FAA.